ExodusPoint Capital Management’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-23,732
Closed -$99.4K 1974
2025
Q3
$99.4K Sell
23,732
-133,818
-85% -$855K ﹤0.01% 1429
2025
Q2
$1.46M Buy
+157,550
New +$1.37M 0.01% 847
2024
Q4
Sell
-422,914
Closed -$4.63M 1955
2024
Q3
$4.63M Buy
+422,914
New +$4.3M 0.03% 454
2024
Q2
Sell
-171,015
Closed -$1.4M 1905
2024
Q1
$1.4M Buy
171,015
+6,793
+4% +$55.7K 0.01% 835
2023
Q4
$1.38M Buy
164,222
+39,250
+31% +$455K 0.01% 691
2023
Q3
$2.14M Sell
124,972
-27,166
-18% -$534K 0.02% 654
2023
Q2
$3.53M Buy
152,138
+27,913
+22% +$545K 0.03% 578
2023
Q1
$2.19M Buy
124,225
+16,603
+15% +$395K 0.02% 838
2022
Q4
$2.93M Buy
107,622
+94,044
+693% +$1.95M 0.04% 509
2022
Q3
$234K Buy
+13,578
New +$259K ﹤0.01% 1595
2021
Q3
Sell
-5,408
Closed -$208K 2540
2021
Q2
$208K Buy
+5,408
New +$185K ﹤0.01% 1959
2021
Q1
Sell
-43,250
Closed -$1.65M 2520
2020
Q4
$1.65M Buy
+43,250
New +$1.8M 0.02% 623

Other funds holding REPL

ExodusPoint Capital Management's REPL Position: Q4 2025 in Review

ExodusPoint Capital Management sold out of Replimune Group (REPL) in Q4 2025, closing a stake of 23,732 shares — an estimated $99.4K sold.

ExodusPoint Capital Management first reported a position in REPL in Q4 2020 and held it in 12 quarters. The position peaked at $4.63M in Q3 2024. 164 funds tracked by Wall St. Rank hold REPL as of Q4 2025.

  • ExodusPoint Capital Management reported no remaining Replimune Group position as of Q4 2025 after selling out during the quarter.
  • ExodusPoint Capital Management sold 23,732 Replimune Group shares in Q4 2025, an estimated $99.4K.
  • ExodusPoint Capital Management first reported a position in Replimune Group in Q4 2020 and held it in 12 quarters.
  • ExodusPoint Capital Management's Replimune Group position peaked at $4.63M in Q3 2024.
  • 164 funds tracked by Wall St. Rank held Replimune Group as of Q4 2025.

Based on ExodusPoint Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.